Humira

AbbVie accuses rival of stealing blockbuster ‘trade secrets’ as clock ticks down on biosimilar assault
AbbVie accuses rival of stealing blockbuster ‘trade secrets’ as clock ticks down on biosimilar assault
Endpoints
AbbVie
Humira
trade secrets
Alvotech
Flag link:
13 leading drugmakers' top 3 drugs by revenue in 2020
13 leading drugmakers' top 3 drugs by revenue in 2020
Beckers Hospital Review
drug sales
revenue
AbbVie
Humira
Flag link:
AbbVie looks to shed Allergan's legacy women's health unit as it hunkers down for Humira biosim doomsday — report
AbbVie looks to shed Allergan's legacy women's health unit as it hunkers down for Humira biosim doomsday — report
Endpoints
AbbVie
Women's Health
Allergan
Humira
M&A
Flag link:
AbbVie's immunology newbies Skyrizi and Rinvoq pick up the slack from declining Humira, but safety questions dog execs
AbbVie's immunology newbies Skyrizi and Rinvoq pick up the slack from declining Humira, but safety questions dog execs
Fierce Pharma
AbbVie
FDA
Skyrizi
Rinvoq
Humira
earnings
Flag link:
Pharma TV ad spenders blow up December with spendiest month of 2020
Pharma TV ad spenders blow up December with spendiest month of 2020
Fierce Pharma
television ads
AbbVie
Humira
Novo Nordisk
DTC ads
Flag link:
AbbVie eyes Humira matching move into psoriatic arthritis for immunology follow-up Skyrizi
AbbVie eyes Humira matching move into psoriatic arthritis for immunology follow-up Skyrizi
Endpoints
AbbVie
Humira
psoriatic arthritis
Skyrizi
Flag link:
AbbVie chases its next golden goose for a post-Humira future with new ulcerative colitis data for Rinvoq
AbbVie chases its next golden goose for a post-Humira future with new ulcerative colitis data for Rinvoq
Endpoints
AbbVie
Allergan
Humira
Rinvoq
Flag link:
How AbbVie Beat Expectations in Q3
How AbbVie Beat Expectations in Q3
Motley Fool
AbbVie
earnings
Humira
Flag link:
4 AbbVie brands land on pharma's top TV spenders list for September
4 AbbVie brands land on pharma's top TV spenders list for September
Fierce Pharma
television ads
DTC ads
AbbVie
Humira
Skyrizi
Rinvoq
Ubrelvy
Flag link:
Oxford University to test AbbVie's Humira as COVID-19 treatment
Oxford University to test AbbVie's Humira as COVID-19 treatment
Beckers Hospital Review
AbbVie
Humira
University of Oxford
clinical trials
COVID-19
Flag link:
AbbVie to face House committee subpoena over Humira, Imbruvica pricing strategies: chairwoman
AbbVie to face House committee subpoena over Humira, Imbruvica pricing strategies: chairwoman
Fierce Pharma
AbbVie
Imbruvica
Humira
drug pricing
patents
Flag link:
Pfizer's Unheralded Franchise That's Worth Billions of Dollars
Pfizer's Unheralded Franchise That's Worth Billions of Dollars
Motley Fool
Pfizer
biosimilars
Humira
Inflectra
Remsima
Remicade
autoimmune disease
JNJ
Flag link:
AbbVie OKs $24M lawsuit settlement, accused of using nurses to boost Humira
AbbVie OKs $24M lawsuit settlement, accused of using nurses to boost Humira
Beckers Hospital Review
AbbVie
Humira
kickbacks
nurses
physicians
Flag link:
AbbVie, already famous for its Humira strategy, forms another 'patent wall' around Imbruvica: report
AbbVie, already famous for its Humira strategy, forms another 'patent wall' around Imbruvica: report
Fierce Pharma
AbbVie
Humira
patents
Imbruvica
cancer
Flag link:
AbbVie's Humira on Steroids (Literally) Treats Rheumatoid Arthritis Better Than the Original
AbbVie's Humira on Steroids (Literally) Treats Rheumatoid Arthritis Better Than the Original
Motley Fool
AbbVie
Humira
clinical trials
ABBV-3373
monoclonal antibodies
Flag link:
AbbVie's Humira defense may keep prices high, but it's still legal, judge rules
AbbVie's Humira defense may keep prices high, but it's still legal, judge rules
Fierce Pharma
AbbVie
Humira
biosimilars
patents
Flag link:
AbbVie touts Humira defense strategy abroad as a positive sign for forthcoming U.S. battle
AbbVie touts Humira defense strategy abroad as a positive sign for forthcoming U.S. battle
Fierce Pharma
AbbVie
Humira
generics
patents
Flag link:
AbbVie's plan to replace Humira is ahead of schedule
AbbVie's plan to replace Humira is ahead of schedule
BioPharma Dive
AbbVie
Humira
Skyrizi
immunology
Flag link:
Should AbbVie break up Allergan? If it wants to make up for Humira, then yes, analyst says
Should AbbVie break up Allergan? If it wants to make up for Humira, then yes, analyst says
Fierce Pharma
AbbVie
Allergan
M&A
Humira
Botox
Flag link:
Roche's Ocrevus, GSK's Dovato ads top November TV spending charts—behind Humira, of course
Roche's Ocrevus, GSK's Dovato ads top November TV spending charts—behind Humira, of course
Fierce Pharma
drug ads
television ads
Roche
Ocrevus
GSK
Dovato
AbbVie
Humira
Flag link:

Pages